While Oxfam's critiques were largely hyperbolic and fabricated, it is true that, in many cases, costs may rise with the implementation of a healthcare PPP. With the provision of, say, additional screenings and more robust treatments, a healthcare PPP may actually be more expensive than traditional procurement methods in the immediate term. But, those improved services often result in longer periods of wellness in the future, which dramatically reduce costs. It is important for critics to assess cost structures in the long term for PPPs-generally five years or longer. Many criticisms can thus be addressed by noting that accusations of excessive cost are premature, especially when traditional procurement routinely suffers from cost overruns and service delivery delays.